Advertisement

Topics

FY2020 EPS Estimates for Vanda Pharmaceuticals Inc. Decreased by Jefferies Group

17:40 EST 11 Nov 2017 | Topix

Vanda Pharmaceuticals Inc. - Equities researchers at Jefferies Group cut their FY2020 earnings per share estimates for Vanda Pharmaceuticals in a report issued on Wednesday. Jefferies Group analyst M. Andrews now anticipates that the biopharmaceutical company will post earnings of $1.27 per share for the year, down from their prior estimate of $1.30.

Original Article: FY2020 EPS Estimates for Vanda Pharmaceuticals Inc. Decreased by Jefferies Group

NEXT ARTICLE

More From BioPortfolio on "FY2020 EPS Estimates for Vanda Pharmaceuticals Inc. Decreased by Jefferies Group"

Advertisement
Quick Search
Advertisement
Advertisement